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Abstract
Background: About 7 % of karyotypically balanced chromosomal rearrangements (BCRs) are associated with congenital
anomalies due to gene or regulatory element disruption, and cryptic imbalances on rearranged chromosomes. Rare
familial BCRs segregating with clinical features are a powerful source for the identifying of causative genes due to the
presence of several affected carriers.
Case presentation: We report on a karyotypically balanced translocation t(2;22)(p13;q12.2) associated with variable
learning disabilities, and craniofacial and hand dysmorphisms, detected in six individuals in a three-generation family.
Combined a-CGH, FISH and mate-pair sequencing revealed a ten-break complex rearrangement, also involving
chromosome 5. As the consequence of the segregation of the derivative chromosomes der(2), der(5) and der(22),
different imbalances were present in affected and clinically normal family members, thus contributing to the clinical
variability. A 6.64 Mb duplication of a 5q23.2-23.3 segment was the imbalance common to all affected individuals.
Although LMNB1, implicated in adult-onset autosomal dominant leukodystrophy (ADLD) when overexpressed, was
among the 18 duplicated genes, none of the adult carriers manifested ADLD, and LMNB1 overexpression was not
detected in the two tested individuals, after qRT-PCR. The ectopic location of the extra copy of the LMBN1 gene on
chromosome 22 might have negatively impacted its expression. In addition, two individuals presenting with more
severe learning disabilities carried a 1.42 Mb 2p14 microdeletion, with three genes (CEP68, RAB1A and ACTR2),which
are candidates for the intellectual impairment observed in the previously described 2p14p15 microdeletion syndrome,
mapping to the minimal overlapping deleted segment. A 5p15.1 deletion, encompassing 1.47 Mb, also detected in the
family, did not segregate with the clinical phenotype.
Conclusion: The disclosing of the complexity of an apparently simple two-break familial rearrangement illustrates the
importance of reconstructing the precise structure of derivative chromosomes for establishing genotype-phenotype
correlations.
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Background
About 7 % of karyotypically balanced chromosomal rear-
rangements (BCR) are associated with congenital anomal-
ies [1]. Truncation of dosage sensitive genes [2, 3] or
regulatory genomic landscapes [4], and cryptic imbalances
on the rearranged chromosomes [5] are often the under-
lying pathogenic mechanisms in disease-associated BCRs.
Rare familial BCRs segregating with clinical features con-
tribute to the identification of causative genes due to the
presence of several affected carriers [6, 7]. We describe a
three–generation Brazilian family with six individuals
carrying a karyotypically balanced chromosomal transloca-
tion t(2;22)(p13;q12.2) associated with variable learning
disability and craniofacial and hand dysmorphisms. By
array-comparative genomic hybridization (a-CGH), fluor-
escent in situ hybridization (FISH), and mate-pair sequen-
cing (MPS), we demonstrated that the apparently simple
two-way balanced translocation was a more complex
three-chromosome rearrangement, also involving chromo-
some 5, with three novel copy number variations: two
microdeletions at 2p14 and 5p15, and a microduplication
at 5q23.2-23.3. As a consequence of the segregation of the
derivative chromosomes 2, 5 and 22, different imbalances
were present in affected and clinically normal family
members, thus contributing to the clinical variability.
Case presentation
The proband (III-4; Fig. 1), the second child of unrelated
parents, was delivered at term by cesarean section, with
a weight of 2,640 g (5th percentile). For the first five
months, feeding difficulties with regurgitation were fre-
quent. The child was able to sit up without support at
eight months, and walked independently at 16 months.
Speech development was delayed: he spoke only isolated
Fig. 1 The structure of the derivative chromosomes der(2), der(5) and der(22), and their segregation. (a) In addition to the translocation of segments
between chromosomes 2 and 22, a 1.42 Mb segment from 2p14 was found to be inserted into 5p15.1, where a 1.47 Mb deletion was detected; two
other segments at 5p15.1, and one segment at 5p15.1-p14.3 was also rearranged on the der(5), one of them distal and two proximal to the 2p14
insertion; on chromosome 22 a duplicated segment of 6.64 Mb from 5q23.2-q23.3 was inserted into the breakpoint. Arrows point to breakpoints;
localization of the resulting fragments is indicated at right. (b) The rearranged chromosomes – der(2), der(5) and der(22), were present in the proband
(III-4), his mother (II-4), aunt (II-3) and grandmother (I-2), who therefore carried a 5p15 deletion and a 5q23.2q23.3 duplication; the proband’s affected
brother (III-3) and uncle (II-6) inherited the der(2) and der(22), thus carrying a 2p14 deletion and a 5q23.2 duplication; the proband’s clinically normal
brother (III-5) inherited only the der(5), and had a 2p14 duplication and a 5p15 deletion
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words until the age of four years. At six, he was referred
to our Genetic Counseling Service due to learning diffi-
culties. His height (117 cm) and weight (22 kg) were
within the normal range (50th - 75th percentiles). The
patient presented with turricephaly, flattened facies,
short forehead, synophrys, epicanthal folds, normal inner
(28.4 mm) and outer (80.0 mm) intercanthal distances
(both between the 50th and 70th percentiles), long eye-
lids, low nasal bridge, high-arched palate, and small and
low set ears. The hand abnormalities included brachy-
dactyly, cutaneous syndactyly and clinodactyly of the 5th
finger bilaterally, and a single transverse palmar crease
at left. The first interdigital distance was increased in
both feet. At a second clinical evaluation at the age of
15, height was 164 cm (25th percentile) and weight was
62.9 kg (75th percentile). Learning difficulties persisted
and he was referred for speech therapy.
The older brother of the proband (III-3) was delivered at
term, also after cesarean section. Birth weight was 3,250 g
(25th-50th percentiles). He walked independently at
14 months. At eight years, he was referred to our Genetic
Counseling Service due to severe learning difficulties; he
could not read. His height was 135 cm (90th percentile) and
weight was 33 kg (90th - 97th percentile). He had similar
craniofacial dysmorphisms as his brother: turricephaly, flat-
tened facies, high forehead, synophrys, epicanthal folds, low
nasal bridge, high-arched palate, and low set ears; his inner
and outer intercanthal distances were 30 mm (50th - 75th
percentiles) and 82 mm (75th - 90th percentiles), respect-
ively. The hand abnormalities included brachydactyly, cuta-
neous syndactyly, and clinodactyly of the 5th finger. At the
age of 17 years, height was 174 cm (between the 25th and
50th percentiles) and weight was 71.2 kg (between the 50th
and 75th percentiles). Severe learning difficulties persisted.
The mother of the boys (II-4) was evaluated at 32 years
of age. Her height was 155 cm (10th - 25th percentiles)
and her weight was 73 kg (90th - 97th percentiles). She
presented with turricephaly, mid facial hypoplasia, low
set ears, and bilateral brachydactyly and clinodactyly of
the 5th finger. She had learning difficulties. A younger
brother of the proband (III-5) was clinically normal.
The maternal grandmother I-2 (deceased from heart
failure at the age of 77 years), an uncle (II-6) and an
aunt of the proband (II-3), all carriers of the transloca-
tion, presented with similar dysmorphisms and variable
degrees of learning disabilities; the uncle was more se-
verely affected. These three patients were not personally
examined but their clinical conditions were assessed
through photos and familial anamnesis.
Methods
Chromosome analysis (GTG-banding and FISH)
GTG-banding analysis was performed on metaphases
from cultured peripheral blood lymphocytes.
Fluorescent in situ hybridization (FISH)
FISH was performed with BACs and PACs (Additional
file 1: Tables S1 and Additional file 2: Table S2) selected
on the University of California – Santa Cruz – Genome
Browser (UCSC; http://genome.ucsc.edu; hg 19), as
previously described [8].
Array-comparative genomic hybridization (a-CGH)
a-CGH was performed using the Agilent Human
Genome 105 K CGH Microarray (Agilent Technologies
Inc., Santa Clara, CA, USA). The Agilent Human
Genome 60 k CGH Microarray (Agilent Technologies
Inc., Santa Clara, CA, USA), was used for patient III-3
and III-6. The microarray chip was scanned on an
Agilent Microarray Scanner. Data were processed by
Agilent Feature Extraction software 9.5 and analyzed
with Agilent CGH Analytics 3.4 Software with the statis-
tical algorithm ADM-2, and sensitivity threshold 6.7. At
least three consecutive oligonucleotides had to have
aberrant log2 ratios to be called by the software.
Mate-pair sequencing (MPS) library preparation and data
analysis
Mate-pair library was prepared for the genomic DNA of
the proband (III-4) using the Nextera Mate Pair Sample
Preparation kit (Illumina, San Diego, CA, USA). Mate-pair
libraries were sequenced on HiSeq2000 (Illumina), as
paired-end 100 bp reads (2 × 100 bp). After adapter trim-
ming, reads passing Illumina Chastity filtering (>0.6) were
aligned to the human reference genome (hg19), using
Burrows-Wheeler Aligner (BWA) [9]. Sequences with
more than two mismatches were excluded, together with
duplicated sequences corresponding to PCR amplification.
Reads not aligning uniquely were discarded from further
analysis. Paired-reads aligning to different chromosomes,
with unexpected strand orientation or increase/decrease
in insert size, were extracted for further analysis. These
“discordant” paired-reads were analysed by SVDetect [10]
to predict structural variants (SV). The MPS results were
visualized on the Integrative Genomics Viewer [11]. To
identify sample-specific structural variants, the predicted
SVs were compared with in-house mate-pair data sets,
and SVs, which were not unique to the cases, were
excluded. Only SVs supported by at least six independent
pairs of reads were considered. The analysis focused on
chromosomes 2, 5 and 22. Data from FISH and micro-
array analysis were used as guidelines to interpret the
MPS data and to identify “missed” paired-reads necessary
to delineate the derivative chromosomes.
Quantitative reverse transcriptase polymerase chain
reaction (qRT-PCR)
To evaluate the expression of LMNB1, MARCH3 and
FBN2 genes mapping within the detected duplication at
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5q23.2-23.3, qRT-PCR analysis was performed. Total
RNA was extracted from peripheral blood leucocytes
from the proband, his mother and two unrelated
healthy controls (aged 25 to 30 year), using the
NucleoSpin® RNA II kit (Macherey-Nagel, Düren,
Germany). SuperScript III First-strand Synthesis (Invi-
trogen, California, USA) kit was used for preparing
the cDNA. Primers for qRT-PCR were designed for
one amplicon of the LMNB1 (lamin B1), MARCH3
(membrane-associated ring finger (C3HC4) 3, E3 ubi-
quitin protein ligase) and FBN2 (fibrillin 2) cDNAs,
using Primer 3 (Additional file 3: Table S3). The
amplicons were normalized to the ACTB (actin, beta)
gene. qRT-PCR reactions were carried out on an ABI
7500 real-time PCR machine, using the SYBR® green
PCR master mix (Applied Biosystems). All samples
were tested in triplicate. To calculate the relative and
normalized levels of LMNB1, MARCH3 and FBN2 the
data was analyzed using Excel (Microsoft Corporation,
Redmond, WA) and an unpaired student's t test was
performed for statistical analysis.
Results
Investigation of the translocation t(2;22) using a-CGH,
FISH, and MPS
After G-banding, a karyotypically balanced translocation
t(2;22)(p13;q12.2) was detected in the proband (III-4), his
older brother (III-3), mother (II-4), maternal grandmother
(I-2), aunt (II-3) and uncle (II-6) (Fig. 1b). They shared
similar clinical signs, although in variable degrees, II-6
and III-3 presenting with more severe learning disabilities.
The clinically normal brother of the proband (III-5) had a
normal karyotype. In the proband, a-CGH analysis re-
vealed a 1.45 Mb deletion at 5p15.1 and a 6.63 Mb dupli-
cation at 5q23.2-23.3 (Fig. 2a-d). The deletion was
confirmed by FISH (Fig. 2b), and the extra segment of
Fig. 2 Chromosome 5 microdeletion and microduplication detected in the proband. (a) a-CGH (105 K, Agilent): Probes within a 1.45 Mb segment at
5p15.1 were deleted (chr5: 15,097,402-16,551,445; Human GRCh37 Assembly, hg19). The UCSC profile of the region depicts the deletion identified by
a-CGH, which was extended to 1.47 Mb by MPS (chr5:15,073,606-16,552,845) (red), with the four genes mapping to this segment. (b) FISH probes
RP1-137K24 (red signal) and RP1-167G20 (green signal) from the deleted segment, showed signals only on the normal chromosome 5. (c) a-CGH
(105 K, Agilent): Probes within a 6.63 Mb segment on 5q23.2-23.3 were duplicated (chr5: 123,798,118-130,432,974). The UCSC profile depicts
the duplication identified by a-CGH, which was extended to a 6.64 Mb interval by MPS (chr5:123,790,174-130,437,756) (blue), with the 18
genes mapping to this segment. (d) The additional segment of chromosome 5 was found to be inserted into the der(22) breakpoint region,
by FISH, using the probes R11-48C14 (red signal) and RP1-236L2 (green signal) from the duplicated segment. This result was confirmed by
MPS analysis (Table 1 and Additional file 7: Table S4)
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chromosome 5 was found to be inserted into the der(22)
breakpoint region (Fig. 2d). a-CGH and/or FISH detected
the 5p15.1 deletion in three affected individuals [the
mother (II-4), maternal grandmother (I-2) and aunt (II-3)],
but also in the phenotypically normal brother (III-5) of the
proband (Additional file 4: Figure S1). The insertion of
5q23.2-23.3 into the der(22), however, was detected only in
the affected individuals (Additional file 5: Figure S2). Four
and 18 genes are located within the deleted and duplicated
segments of chromosome 5, respectively (Fig. 2a and c). In
addition, a 1.24 Mb 2p14 deletion was identified by a-CGH
in the proband’s affected brother (III-3; Figs. 1b and 3a-b).
Fig. 3 Microdeletion at 2p14 detected in two family members, and previously described overlapping deletions. (a) a-CGH (60 K, Agilent): Probes within
a 1.24 Mb segment at 2p14 (chr2:65,237,764-66,484,321) were deleted in the proband’s affected brother (III-3). (b, c) FISH probe RP11-263L17 (red signal)
from the deleted segment, hybridized to one chromosome 2 only, (b) confirming the deletion in II-3 and (c) showing that it was also present in III-6, the
affected uncle of the proband. (d) The UCSC profile of the 2p15p14 region depicts the deletion identified by a-CGH, which was extended to a 1.42 Mb
interval by MPS (chr2:66,646,777-65,220,481) (red). Seven overlapping microdeletions (red bars) associated with mild intellectual disability and minor
dysmorphic features were previously reported [30–32]. The CEP68, RAB1A and ACTR2 genes which maps to the minimal overlapping deletion interval
are candidates for the intellectual impairment in the 2p14p15 microdeletion syndrome
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This deletion was also detected in the proband’s affected
uncle (II-6; Figs. 1b and 3c). Five genes map to the deleted
segment of chromosome 2 (Fig. 3d). In the phenotypically
normal brother of the proband (III-5; Fig. 1b), this same
2p14 segment was duplicated, inserted into the short arm
of the der(5) (Additional file 6: Figure S3). As expected, the
other carriers of the der(5) – the proband (III-4), his grand-
mother (I-2), mother(II-4) and aunt (II-3), had the 2p14
segment inserted into der(5) as well (Additional file 6:
Figure S3); they did not have any imbalance of chromo-
some 2, since they also carried the der(2). The affected
brother (III-3) and uncle (II-6) of the proband both carried
the deletion, since they inherited the normal chromosome
5 and not the der(5) from their respective mothers. No
copy number variations were detected on chromosome 22.
The breakpoints (BPs) of chromosomes 2 and 22 were
mapped by FISH (Table 1, Additional file 1: Table S1
and Additional file 2: Table S2). Due to the complexity
of the a-CGH and FISH results, MPS was performed in
the proband. This confirmed the seven BPs and the
structural variations predicted by the combined karyo-
typing, FISH and a-CGH results (Table 1 and Additional
file 7: Table S4), and further narrowed down the BPs to
1.5-5.7 kb segments. Based on the BPs delimited by
MPS, the deletion and duplication on chromosome 5
were extended to 1.47 Mb and 6.64 Mb, respectively. As
the 2p14 segment inserted into der(5) detected in the
proband (III-4) corresponds to the 2p14 deleted segment
in his affected brother (III-3) and uncle (II-6), and to the
duplicated segment in the phenotypically normal brother
(III-5), the 2p14 inserted/deleted/duplicated segment
could be delimited to 1.42 Mb. In addition, three novel
breakpoints on chromosome 5 were identified by MPS,
proximal to the deletion at 5p15, and the resulting frag-
ments were rearranged on the der(5), one of them distal
and two proximal to the 2p14 insertion. The structure of
the derivative chromosomes der(2), der(5) and der (22)
based on a-CGH, FISH and MPS results are illustrated
in Figs. 1a and Additional file 8: Figure S4. Three
protein-coding genes (SLC1A4: solute carrier family 1
glutamate/neutral amino acid transporter, member 4;
FAM134B: family with sequence similarity 134, member
B; TTC28, tetratricopeptide repeat domain 28) and the
non-coding RNA gene (MEIS1-AS3: MEIS1 antisense
RNA 3) were disrupted by the rearrangement break-
points (Table 1).
LMNB1, MARCH3 and FBN2 expression analysis
Although LMNB1 is located in the 5q23.2-23.3 duplicated
segment, transcript levels were normal in peripheral blood
cells from the proband, and decreased in his mother, as
demonstrated by qRT-PCR (Additional file 9: Figure S5).
In contrast, increased expression of MARCH3 and FBN2
transcripts was detected in the proband and his mother, in
accordance with their mapping within the 5q23.2-23.3
duplicated segment (Additional file 9: Figure S5). The
decreased levels of LMNB1 transcripts in the mother of
the proband in comparison to her son might be due to an
age-related effect [12].
Discussion
We studied a karyotypically balanced translocation segre-
gating in a family in association with learning disabilities of
variable degrees and craniofacial and hand dysmorphisms.
By combining a-CGH, FISH and MPS, the rearrangement,
first identified by G-banding as a two-way balanced trans-
location, was found to be a ten-break rearrangement,
resulting in six structural variations, which also involved
chromosome 5 (Fig. 1a). This rearrangement presumptively
originated in an ancestor of the proband’s grandmother,
since she did not carry the der(5) with a deletion of the
segment corresponding to the 5q23.2-23.3 fragment
inserted into der(22); a meiotic exchange between the nor-
mal chromosome 5 and the original der(5) would have
Table 1 Breakpoints (BPs) involved in the t(2;5;22), mapped by FISH, a-CGH and MPS, and truncated genes
Chr BPs mapped by FISH BPs mapped by a-CGH BPs mapped by MPS Band Disrupted gene
Position
(hg19)
Interval
(bp)
Position
(hg19)
Interval
(bp)
Position
(hg19)
Interval
(bp)
chr2 65,209,004-65,265,044 56,040 65,218,054-65,220,481 2,427 2p14 SLC1A4
chr2 66,540,604-66,723,065 182,461 66,646,777-66,652,554 5,777 2p14 MEIS1-AS3
chr5 15,065,696-15,097,402 31,707 15,069,309-15,073,606 4,297 5p15.1
chr5 16,551,445-16,590,384 38,940 16,552,845-16,557,142 4,297 5p15.1 FAM134B
chr5 18,178,446-18,182,480 4,034 5p15.1
chr5 21,162,845-21,167,142 4,297 5p14.3
chr5 25,131,744-25,133,892 2,148 5p14.1
chr5 123,737,596-123,798,118 60,523 123,785,877-123,790,174 4,297 5q23.2
chr5 130,432,974 – 130,476,355 43,382 130,437,756-130,442,053 4,297 5q23.3
chr22 28,654,643-28,691,257 36,614 28,658,943-28,660,443 1,500 22q12.1 TTC28
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given rise to the detected der(5) with a normal long arm
and an insertion of the 2p14 segment into the short arm
(Additional file 8: Figure S4).
Despite the presence of three rearranged chromo-
somes – der(2), der(5) and der(22), only the der(2) and
der(22) chromosomes segregated with clinical features
(Fig. 1b). Common to all affected individuals were the
6.64 Mb duplication at 5q23.2-23.3, together with dis-
ruption of SLC1A4 and MEIS1-AS3, on chromosome 2,
and disruption of TTC28, on chromosome 22. The
1.47 Mb deletion at 5p15, which is a novel copy number
variation (CNV) not reported in the Database of Genomic
Variants (DGV), did not segregate with the clinical pheno-
type since the clinically normal brother of the proband
(III-5) carried this deletion. He also carried another CNV
not reported in DGV, a 1.42 Mb 2p14 duplication; his
brother (III-3) and uncle (II-6) carried a deletion of this
same fragment. Although this deletion might cause cogni-
tive impairment, as discussed below, duplications of
CEP68, RAB1A, ACTR2 and SPRED2, located within the
duplicated segment, have not been reported before. The
microimbalances detected in the proband’s normal
brother (III-5) highlight the importance of investigating
unaffected individuals in the evaluation of the clinical im-
pact of familial rearrangements.
There are some reports of larger 5q duplications, which
include the present 6.64 Mb 5q23.2-23.3 duplicated seg-
ment [13]. However, these previously reported duplica-
tions varied in size, the smallest being 14 Mb, and differed
in gene content, thus making phenotype-genotype correla-
tions difficult to infer. Among the 18 genes encompassed
by the 5q23.2-23.3 duplication in the present family,
LMNB1 is the only gene known to cause disease due to in-
creased expression. LMNB1 duplications cause adult-
onset autosomal dominant leukodystrophy (ADLD; MIM
169500) [14]. Three other disease genes maps within the
6.64 Mb 5q23.2-23.3 duplicated segment: FBN2 (congeni-
tal contractural arachnodactyly), ALDH7A (pyridoxine-
dependent form of epilepsy) and MEGF10 (myopathy,
areflexia, respiratory distress, and dysphagia). The disor-
ders associated with these genes are caused by gain of
function (FBN2) or loss of function mutations (MEGF10
or ALDH7A), and it is unknown if overexpression of these
genes is pathogenic. Also, 14 genes, which have not been
implicated in diseases before, map within the duplication
(PHAX, MARCH3, SLC12A2, SLC27A6, ADAMTS19,
CTXN3, CHSY3, ZNF608, GRAMD3, C5orf48, C5orf63,
ISOC1, PRRC1, KIAA1024L). Since this novel CNV was
detected only in affected family members, duplication of
one or more of these 14 genes likely contributes to the
phenotype.
ADLD is a slowly progressive neurological disorder char-
acterized by symmetrical widespread myelin loss in the
central nervous system. The first signs of the disease, which
includes cerebellar, pyramidal, and autonomic dysfunction,
appear in the fourth and fifth decades of life [15]. None of
the adults in the family described here, presently in the
fourth and fifth decades of life [the proband's mother (aged
46 years), aunt (aged 53 years) and uncle (aged 45 years)],
and the grandmother, deceased at the age of 77 years due
to heart failure, showed symptoms of this disease. As deter-
mined by qRT-PCR, the LMNB1 gene was not overex-
pressed in blood cells from the proband or his mother
(Additional file 9: Figure S5). Increased LMNB1 transcript
level is detected not only in brain but also in blood from
individuals affected by ADLD [16, 17]. On the other hand,
in the proband and his mother, FBN2 and MARCH3 had a
2 to 3.8 fold increase in expression, demonstrating that the
extra copy of both genes inserted into the der(22) were
functional; these findings indicated that the normal and
decreased expression of LMNB1 in the proband and his
mother, respectively, did not result from the silencing of
the entire 5q23.2-23.3 segment on the der(22) due to
“position effect”. Previously reported duplications including
LMNB1 in ADLD patients ranged in size from 128 kb to
478 kb; common to all these patients was a duplicated
~72 kb segment (chr5:126,102,443-126,174,517), encom-
passing the entire coding sequence of LMNB1, and the
regions 9.8 kb upstream and 1.8 kb downstream the gene
[17]. This interval was duplicated in the present family.
Furthermore, a recently isolated LMNB1 enhancer located
120 kb upstream of LMNB1 [18] was also translocated to
the der(22). However, the extra copy of LMBN1 was
located on the der(22) chromosome, while all previously
reported LMNB1 duplications in patients with ADLD were
in tandem [14, 16, 17, 19, 20]. The disruption of LMNB1
long range regulation or the interference of sequences on
chromosome 22 (centromeric to LMNB1) or from the
translocated chromosome 2 (telomeric to LMNB1) might
have negatively impacted the expression of the LMNB1
copy located on the der(22). Considering the position of
the gene within the duplicated segment, disruption of
LMNB1 regulation would be due to the separation of an
enhancer located more than 2.3 Mb upstream or 4.3 Mb
downstream from LMNB1. The possibility also exists that
other genes within the 5q23.2-q23.3 segment negatively
affects LMNB1 expression. Regardless of the mechanism
interfering with LMNB1 expression, this study illustrates
the importance of evaluating the quantitative level of tran-
scripts in carriers of duplications encompassing LMNB1,
particularly considering that ADLD is a late-onset neurode-
generative disorder.
SLC1A4 is also disrupted in all carriers of the der(2)
chromosome in the present family. SLC1A4 encodes a
neutral small amino acid transporter, and is ubiquitously
expressed [21], particularly in glial cells, and during
brain development [22]. Recently, recessive mutations in
SLC1A4 were described in patients presenting with
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developmental delay, microcephaly and hypomyelination
[23–25]. Most patients were homozygous for missense
mutations (p.E256K, p.L315fs, and p.R457W) [23, 24], but
one of them carried a missense (E256K) and a nonsense
(Leu315Hisfs*42) mutations [24]. Mutated proteins were
shown to abolish (p.R457W) or markedly reduce (p.E256K)
L-serine transport [25], demonstrating that SLC1A4 loss of
function, rather than a gain of function mechanism, caused
the clinical features. Heterozygous carriers of the missense
and nonsense mutations in SLC1A4 were clinically normal,
arguing against a causative role of the SLC1A4 truncation
in the present family. The TTC28 gene on chromosome 22
and the MEIS1-AS3 non coding RNA on chromosome 2
were also disrupted by the breakpoints of the rearrange-
ment. TTC28 and MEIS1-AS3 have not been associated
with any known diseases and their phenotypic impact on
the carriers of the der(2) and der(22) chromosomes
remains unknown.
The t(2;5;22) could have also impacted the long range
regulation of gene(s) located near the breakpoints. The
breakpoint on chromosome 2 that disrupted MEIS-S3
occurred approximately 10 kb from the MEIS1 gene
(Meis homeobox 1). SNPs within MEIS1 were associated
with the Restless Legs syndrome (RLS), a neurologic
sleep/wake disorder [26, 27]. Although there is no evi-
dence that MEIS-S3 disruption affects MEIS1 expression,
the centromeric breakpoint on chromosome 2 occurred
within the same topological domain as MEISI [28], and
might have altered its long range regulation. Members
of the reported family do not present RLS symptoms,
but the role of MESI1 in the development of the central
nervous system [29] could implicate MESI1 as candidate
for the learning disabilities observed in the family.
Although the six translocation carriers presented with
learning disabilities, these were more pronounced in the
proband’s affected brother (III-3) and uncle (II-6), who
were the only carriers of the 1.42 Mb chromosome 2 dele-
tion. Seven microdeletions, all extending beyond the
1.42 Mb deletion described here, have been previously re-
ported in association with intellectual disability and minor
dysmorphic features, pointing to a 2p14p15 microdeletion
syndrome [30–32] (Fig. 3d). The 1.42 Mb deletion detected
in III-3 and II-6 is the smallest yet to be reported, encom-
passing SLC1A4, CEP68 (centrosomal protein 68 kDa),
RAB1A (RAB1A, member the RAS oncogene family);
ACTR2 (ARP2 actin-related protein 2 homolog), and
SPRED2 (Sprouty-related, EVH1 domain containing 2).
SLC1A4 was disrupted in all six affected family members,
but, this variant is likely not pathogenic in the heterozy-
gous state, as discussed above. CEP68, RAB1A and ACTR2,
mapping to the minimal overlapping deleted segment ap-
pear as candidates contributing to intellectual impairment
in the 2p14p15 microdeletion syndrome (Fig. 3d). RAB1A
and ACTR2 are involved in neuronal differentiation and
regulation of axon guidance [30]. CEP68 encodes a centro-
somal protein; CEP proteins have an important role in
neurogenesis in the developing human brain, as demon-
strated by the clinical effect of homozygosity for recessive
mutations in CEP genes, known to cause primary
microcephaly [33]. However, while III-3 and II-6 had
severe learning difficulties, the other seven patients with
2p14p15 microdeletions presented with intellectual disabil-
ity [30–32]. This suggests that, in addition to the gene(s)
encompassed by the deletion described here, other
gene(s) contribute to the intellectual impairment in the
2p14p15 microdeletion syndrome. Most of the 2p14p15
microdeletion patients also present with genitourinary
defects [31, 32] a feature associated with the loss of
OTX1 (orthodenticle homeobox1) at 2p15 [32]. The
absence of genitourinary defects in III-3 and II-6,
whose deletion does not include OTX1, is in line with
the role of OTX1 in the development of the genitouri-
nary tract.
The challenge to establish genotype-phenotype cor-
relations in carriers of chromosomal rearrangements
extends beyond a particular DNA sequence to reach
the genomic context [34]. Although several genes
have been directly affected by the herein described
t(2;5;22), this rearrangement might have impacted the
genetic network by altering the physical relationship
between chromatin domains, thus contributing to the
clinical phenotype.
Conclusions
The disclosing of the complexity and segregation of an
apparently simple two-way rearrangement illustrates the
importance of reconstructing the precise structure of
derivative chromosomes for genotype-phenotype correla-
tions. As the consequence of the segregation of the deriva-
tive chromosomes 2, 5 and 22, different imbalances were
present in affected and clinically normal family members,
thus contributing to the clinical variability. A 1.42 Mb 2p14
microdeletion, associated with more severe learning disabil-
ities, pinpoints CEP68, RAB1A and/or ACTR2 as candi-
date(s) for the intellectual impairment in the previously
described 2p14p15 microdeletion syndrome. The absence
of LMNB1 overexpression, despite the presence of an
additional copy of the gene, highlights the importance of
genomic topology in disease, supporting the indication of
evaluating genetic findings in the genomic context.
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Additional file 4: Figure S1. Segregation of the 5p15.1 deletion. FISH
using probes RP1-137K24 (red signal) and RP1-167G20 (green signal),
mapping to the deleted segment at 5p15.1, revealed signals only on the
normal chromosome 5 on metaphase spreads of the mother (II-4), maternal
grandmother (I-2), aunt (II-3), and in the phenotypically normal brother (III-5)
of the proband. Both probes hybridized to both chromosomes 5 on
metaphases of the affected brother (III-3) and uncle of the proband
(II-6). These results demonstrated that the deletion at 5p15.1 did not
segregate with the clinical phenotype in the family. (TIFF 2444 kb)
Additional file 5: Figure S2. Segregation of the 5q23.2-q23.3 duplication.
FISH using probes RP11-48C14 (red signal) and RP1-236L2 (green signal),
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and an addition signal on the derivative chromosome 22, on metaphases
spreads of all affected individuals in the family. Hybridization signals were only
observed on both chromosomes 5 in the proband’s normal brother (III-5).
These results demonstrated that the duplication at 5q23.2-q23.3 segregated
with the clinical phenotype in the family. (TIFF 2394 kb)
Additional file 6: Figure S3. Segregation of the 2p14 insertion into the
short arm of chromosome 5. FISH using probe RP11-263L17 (red signal),
mapping at 2p14, hybridized to the normal chromosome 2 and to the
derivative 5 on metaphase spreads of the proband (III-4), his grandmother
(I-2), mother (II-4) and aunt (II-3). On metaphase spreads of the phenotypically
normal brother of the proband (III-5), probe RP11-263 L17 hybridized to the
normal chromosome 2 and to the derivative 5. Probe RP11-281O15, mapping
at 5q35.3 (green signals), was used as control for patients I-2, II-4, III-4 and III-5.
Probe RP11-325M10 mapping at 2q33.3 (green signal), was used as control for
patient II-3. These results indicated that the 2p14 segment was inserted into
the chromosome 5 short arm, the same chromosome harbouring the
5p15.1 deletion. The phenotypically normal brother of the proband (III-5),
being a carrier of the der(5), had a 2p14 duplication. The proband’s affected
brother (III-3) and uncle (II-6), who did not carry the der(5), had the
corresponding deletion (Fig. 3). (TIFF 962 kb)
Additional file 7: Table S4. Breakpoint junctions involved in the t(2;5;22)
identified by mate-pair sequencing data. (XLSX 12 kb)
Additional file 8: Figure S4. Mechanism of formation of the t(2;5;22)
based on MPS data. (A) The rearrangement might have originated from
ten occurring breaks (arrows): two on the short arm of chromosome 2,
five breaks on the short arm and two on the long arm of chromosome 5, and
one break on the long arm of chromosome 22. (B) The resulting fragments
(C) rejoined randomly, a fragment from the short arm of chromosome 5
being lost. (D) This rearrangement presumptively originated in an ancestor of
the proband’s grandmother, since she did not carry the der(5) with a deletion
of the segment corresponding to the 5q23.2-23.3 fragment inserted into
der(22). A meiotic exchange between the normal chromosome 5 and the
original der(5) would give rise to the observed der(5) with a normal long arm
and an insertion of the segment 2p14 into the short arm. (E) The derivative
chromosomes 2, 5 and 22 detected in the family, and their normal
homologues are depicted. (TIFF 3425 kb)
Additional file 9: Figure S5. LMNB1, MARCH3 and FBN2 expression
determined by qRT-PCR. The diagram depicts the expression of LMNB1,
MARCH3 and FBN2 in peripheral blood cells from the proband (III-4) and
his mother (II-4), relative to healthy controls (n = 2). LMNB1 transcript
levels did not differ between the proband and controls, but were
decreased in his mother, both carriers of the duplication at 5q23.2-23.3,
encompassing the LMNB1. The decreased levels of LMNB1 transcripts in the
mother of the proband relative to her son might be due to an age-related
effect [12]. On the other hand, increased transcript levels of FBN2 and
MARCH3, also mapping to the duplicated interval, were observed in both
carriers. All samples were tested in triplicate (diagram represents mean
values), and the ACTB expression was used to calculate the relative and
normalized levels of LMNB1, MARCH3 and FBN2 transcripts. Error bars
denote standard error of the mean (SEM). P values for fold change in
expression are indicated (unpaired Student's t test). (TIFF 1845 kb)
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